MiMedx Group
MDXG
Revenue for MiMedx Group (MDXG)
Revenue in 2023 (TTM): $0.32 B
According to MiMedx Group's latest financial reports the company's current revenue (TTM
) is $0.33 B.
In 2022 the company made a revenue of $0.26 B an increase over the years 2021 revenue that were of $0.25 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for MiMedx Group from 2010 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.32 B | 20.03% |
| 2022 | $0.26 B | 3.57% |
| 2021 | $0.25 B | 4.18% |
| 2020 | $0.24 B | -17.05% |
| 2019 | $0.29 B | -16.67% |
| 2018 | $0.35 B | 11.82% |
| 2017 | $0.32 B | 31.07% |
| 2016 | $0.24 B | 30.82% |
| 2015 | $0.18 B | 58.43% |
| 2014 | $0.11 B | 99.77% |
| 2013 | $59.18 M | 118.75% |
| 2012 | $27.05 M | 248.61% |
| 2011 | $7.76 M | 883.74% |
| 2010 | $0.78 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Medtronic MDT | $32.32 B | 9,561.89% | 🇮🇪 Ireland |
 Teleflex TFX | $2.97 B | 789.21% | 🇺🇸 USA |
 Steris STE | $5.40 B | 1,516.51% | 🇮🇪 Ireland |
 NuVasive NUVA | $1.22 B | 266.57% | 🇺🇸 USA |
 Hill-Rom HRC | $3.01 B | 802.42% | 🇺🇸 USA |
 CryoLife CRY | $0.29 B | -10.66% | 🇺🇸 USA |